Artiva Biotherapeutics, Inc. Common Stock (ARTV)
Healthcare
Biotechnology
10.80 $
+6.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Artiva Biotherapeutics, Inc. Common Stock (ARTV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -21 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -11 | -11 | -15 | -14 | -12 | -15 | -20 | -23 | -19 | -15 | -21 | -78 | |
| 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.3 | 1.1 | 0.7 | 2.7 | |
| 2.5 | 1.4 | 1.4 | 1.4 | 1.5 | 1.9 | 2.2 | 2.1 | 1.5 | 1.6 | 1.6 | 1.6 | 6.4 | |
| -3.5 | -24 | -1.1 | -3.0 | 0.0 | 3.0 | -0.3 | -1.5 | -3.4 | 4.9 | -6.4 | 0.5 | -4.4 | |
| 0.6 | 0.2 | 0.6 | 0.0 | 0.5 | 0.1 | 0.1 | 0.5 | 1.1 | 0.6 | 0.4 | 0.2 | 2.3 | |
| -21 | -0.5 | -2.7 | 9.8 | 1.3 | -131 | -1.0 | 10.0 | 21 | 16 | 16 | 15 | 69 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 167 | -4.2 | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| 0.0 | 23 | 1.0 | 0.0 | -1.6 | 164 | 0.0 | 0.2 | -0.1 | 0.0 | -0.1 | -0.1 | -0.3 | |
| -33 | 12 | -12 | -5.3 | -14 | 22 | -16 | -9.6 | -1.9 | -3.0 | 1.2 | -5.7 | -9.4 | |
| -12 | -11 | -11 | -15 | -14 | -12 | -15 | -20 | -24 | -20 | -15 | -21 | -80 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.